Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

SARAH BETH SHINN

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1467440495
CMS profile
292927
Location
PITTSBURGH, PA

General Payments · PY2018–2024

$4,379.35

  • Reported across 271 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$714.06

36 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $714.06 36

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
GlaxoSmithKline, LLC. $175.66 9
Lilly USA, LLC $165.16 8
Acerta Pharma LLC $96.63 6
Novo Nordisk AS $78.81 4
ABBVIE INC. $71.85 3
Amgen Inc. $44.09 2
Lundbeck LLC $23.38 1
Ardelyx, Inc. $20.38 1
PFIZER INC. $19.67 1
Boehringer Ingelheim Pharmaceuticals, Inc. $18.43 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $647.17 49
PY2019 $994.28 84
PY2020 $400.24 21
PY2021 $447.61 16
PY2022 $632.30 35
PY2023 $543.69 30
PY2024 $714.06 36

Payment records · PY2024 (36)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $20.20 01/18/2024 Food and Beverage Undisputed 01/23/2026 1106088982 CMS
ABBVIE INC. $30.23 05/08/2024 Food and Beverage Undisputed 01/23/2026 1106088984 CMS
ABBVIE INC. $21.42 06/11/2024 Food and Beverage Undisputed 01/23/2026 1106088986 CMS
Amgen Inc. $19.97 02/20/2024 Food and Beverage Undisputed 01/23/2026 1116120479 CMS
Amgen Inc. $24.12 10/07/2024 Food and Beverage Undisputed 01/23/2026 1116120485 CMS
Ardelyx, Inc. $20.38 10/23/2024 Food and Beverage Undisputed 01/23/2026 1146707818 CMS
AstraZeneca Pharmaceuticals LP $14.57 03/21/2024 Food and Beverage Undisputed 01/23/2026 1105901120 CMS
AstraZeneca Pharmaceuticals LP $17.29 04/23/2024 Food and Beverage Undisputed 01/23/2026 1105379525 CMS
AstraZeneca Pharmaceuticals LP $13.53 06/13/2024 Food and Beverage Undisputed 01/23/2026 1105636228 CMS
AstraZeneca Pharmaceuticals LP $18.68 08/14/2024 Food and Beverage Undisputed 01/23/2026 1105696928 CMS
AstraZeneca Pharmaceuticals LP $16.44 09/18/2024 Food and Beverage Undisputed 01/23/2026 1104315450 CMS
AstraZeneca Pharmaceuticals LP $16.12 11/12/2024 Food and Beverage Undisputed 01/23/2026 1104285563 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $18.43 11/21/2024 Food and Beverage Undisputed 01/23/2026 1118020320 CMS
GlaxoSmithKline, LLC. $19.35 01/23/2024 Food and Beverage Undisputed 01/23/2026 1116300836 CMS
GlaxoSmithKline, LLC. $16.03 02/19/2024 Food and Beverage Undisputed 01/23/2026 1116645428 CMS
GlaxoSmithKline, LLC. $20.43 06/04/2024 Food and Beverage Undisputed 01/23/2026 1116553485 CMS
GlaxoSmithKline, LLC. $21.53 07/29/2024 Food and Beverage Undisputed 01/23/2026 1116614340 CMS
GlaxoSmithKline, LLC. $19.98 09/12/2024 Food and Beverage Undisputed 01/23/2026 1116576814 CMS
GlaxoSmithKline, LLC. $14.10 10/15/2024 Food and Beverage Undisputed 01/23/2026 1116300500 CMS
GlaxoSmithKline, LLC. $16.30 10/17/2024 Food and Beverage Undisputed 01/23/2026 1116558767 CMS
GlaxoSmithKline, LLC. $28.33 10/22/2024 Food and Beverage Undisputed 01/23/2026 1116628954 CMS
GlaxoSmithKline, LLC. $19.61 11/27/2024 Food and Beverage Undisputed 01/23/2026 1116581535 CMS
Lilly USA, LLC $21.19 02/12/2024 Food and Beverage Undisputed 01/23/2026 1135343849 CMS
Lilly USA, LLC $19.43 03/19/2024 Food and Beverage Undisputed 01/23/2026 1135366520 CMS
Lilly USA, LLC $16.05 05/09/2024 Food and Beverage Undisputed 01/23/2026 1135415199 CMS
Lilly USA, LLC $20.64 05/14/2024 Food and Beverage Undisputed 01/23/2026 1135415197 CMS
Lilly USA, LLC $23.06 06/20/2024 Food and Beverage Undisputed 01/23/2026 1135343854 CMS
Lilly USA, LLC $23.54 07/16/2024 Food and Beverage Undisputed 01/23/2026 1135415195 CMS
Lilly USA, LLC $18.43 09/04/2024 Food and Beverage Undisputed 01/23/2026 1135417575 CMS
Lilly USA, LLC $22.82 11/20/2024 Food and Beverage Undisputed 01/23/2026 1135366518 CMS
Lundbeck LLC $23.38 08/29/2024 Food and Beverage Undisputed 01/23/2026 1145968942 CMS
Novo Nordisk Inc $18.58 03/07/2024 Food and Beverage Undisputed 01/23/2026 1097080373 CMS
Novo Nordisk Inc $23.37 04/08/2024 Food and Beverage Undisputed 01/23/2026 1097813497 CMS
Novo Nordisk Inc $17.94 06/06/2024 Food and Beverage Undisputed 01/23/2026 1097377773 CMS
Novo Nordisk Inc $18.92 07/30/2024 Food and Beverage Undisputed 01/23/2026 1097528789 CMS
PFIZER INC. $19.67 02/28/2024 Food and Beverage Undisputed 01/23/2026 1132020345 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.